Literature DB >> 12499577

KB-R7943, a Na+/Ca2+ exchange inhibitor, does not suppress ischemia/reperfusion arrhythmias nor digitalis arrhythmias in dogs.

Shigeki Miyamoto1, Bing-Mei Zhu, Kazunori Kamiya, Yoshinobu Nagasawa, Keitaro Hashimoto.   

Abstract

KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea methanesulfonate) has been used as a pharmacological tool to block the Ca(2+) influx-mode of the Na(+)/Ca(2+) exchanger, which is thought to contribute to ischemia/reperfusion and digitalis arrhythmias. We examined effects of KB-R7943 on ischemia/reperfusion arrhythmias in beagle dogs anesthetized with sodium pentobarbital. Lead II ECG and BP were measured. KB-R7943 or the solvent (10% DMSO) was injected i.v. as a bolus, and 5 min later, the left anterior descending coronary artery was occluded for 30 min followed by reperfusion. KB-R7943 at 5 or 10 mg/kg increased BP without changing ECG parameters including the heart rate. Although 5 mg/kg KB-R7943 deceased the number of arrhythmic beats during the ischemic period, mortality due to ischemia/reperfusion was not decreased by KB-R7943 (5 and 10 mg/kg). KB-R7943 at 5 mg/kg also did not suppress the ouabain-induced arrhythmias. These negative results suggest that Na(+)/Ca(2+) exchange inhibition may not be a useful strategy of suppressing arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499577     DOI: 10.1254/jjp.90.229

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

Review 1.  Development and application of Na+/Ca2+ exchange inhibitors.

Authors:  Takahiro Iwamoto; Satomi Kita
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

2.  Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type Ca2+ current in canine ventricular cardiomyocytes.

Authors:  Péter Birinyi; Károly Acsai; Tamás Bányász; András Tóth; Balázs Horváth; László Virág; Norbert Szentandrássy; János Magyar; András Varró; Ferenc Fülöp; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-06       Impact factor: 3.000

3.  The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.

Authors:  Zsófia Kohajda; Nikolett Farkas-Morvay; Norbert Jost; Norbert Nagy; Amir Geramipour; András Horváth; Richárd S Varga; Tibor Hornyik; Claudia Corici; Károly Acsai; Balázs Horváth; János Prorok; Balázs Ördög; Szilvia Déri; Dániel Tóth; Jouko Levijoki; Piero Pollesello; Tuula Koskelainen; Leena Otsomaa; András Tóth; István Baczkó; István Leprán; Péter P Nánási; Julius Gy Papp; András Varró; László Virág
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

Review 4.  Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias.

Authors:  Alexandra Njegic; Claire Wilson; Elizabeth J Cartwright
Journal:  Front Physiol       Date:  2020-09-04       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.